Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

Biotechnology

Healthcare
$9.38 +0.00%

+$0.00 today

Market cap
$622.71M
Beta
-0.53
P/E (TTM)
-8.8
EPS (TTM)
-$2.59
52W Low $8.48High $24.25

Volume 1.30M

Average 0.54M

BCAX Change in Working Capital

Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.

Bicara Therapeutics Inc. Common StockNASDAQ: BCAX

Change in Working Capital · Q1 FY2026 · quarter ended Mar 2026

Change in working capital grows, but more slowly than its trailing trend

Q1 FY2026 change in working capital of $12.19M rose 137.5% year over year, behind the +483.9% change in trailing-twelve-month change in working capital. Sequentially, it rose 44.4% from the prior quarter. Over 3 fiscal years it compounded at +44.1% a year.

Context

  • Change in working capital increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +137.5% toward the trailing-twelve-month pace of +483.9%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$12.19M+44.4% QoQ
Last fiscal yearDec 2025
$14.81M+204.8% YoY
LTMMar 2026
$21.87M+483.9% YoY
Change in Working Capital past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+137.5%——
1 year+204.8%——
3-year CAGR+44.1%——
5-year CAGR——
10-year CAGR——

Change in Working Capital history

USD · from the cash flow

Latest · FY2025
14.81M USD
Year-over-year change
+204.8%
3-year CAGR
+44.1%

Change in Working Capital vs competitors

How BCAX compares with its peers on the latest reported figures

  • BCAX's LTM Mar 2026 change in working capital of $21.87M is the largest of the 6 companies compared; the peer median is $3.86M.
  • Its year-over-year change of +483.9% is the highest of 6, against a peer median of +184.8%.
  • Over three fiscal years its annual growth of +44.1% compares with a peer median of +42.1%.
BCAX Competitors Peer median
Change in Working Capital for BCAX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
BCAXBicara Therapeutics Inc. Common StockLTM Mar 2026$21.87M +483.9%+44.1%—
MGNXMacroGenics, Inc.LTM Mar 2026$17.87M +67.2%+66.6%11.4%
CGEMCullinan Therapeutics, Inc.LTM Mar 2026$12.58M +237.9%+8.0%—
CMPXCompass Therapeutics, Inc.LTM Mar 2026$4.47M +184.8%——
CNTXContext Therapeutics Inc.LTM Mar 2026$3.86M +216.5%——
CBIOCrescent Biopharma, Inc.LTM Mar 2026$131.32K -106.7%+42.1%1.1%
VRXAVeraxa Biotech Holding AG—— ———
Peer median (excluding BCAX) $3.86M+184.8%+42.1%6.2%

Competitors are the stored peer set for BCAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(37.85M)(51.99M)(68M)(137.95M)
Depreciation & Amortization10K19K56K406K
Deferred Income Tax0000
Stock-Based Compensation810K1.9M7.4M15.01M
Change in Working Capital4.95M(9.62M)(14.13M)14.81M
Accounts Receivables0000
Inventory0000
Accounts Payables002.64M0
Other Working Capital4.95M(9.62M)(16.77M)14.81M
Other Non-Cash Items810K14.06M(77K)895K
Operating Cash Flow(32.08M)(45.63M)(74.75M)(106.83M)
Capital Expenditures(192K)(586K)(71K)(280K)
Acquisitions (Net)0000
Purchases of Investments000(318.17M)
Sales of Investments0000
Other Investing Activities0062K0
Investing Cash Flow(192K)(586K)(9K)(318.45M)
Debt Repayment0000
Common Stock Issued00332.43M32.26M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities160K149K1.6M0
Financing Cash Flow31.7M272.5M334.03M32.26M
Effect of Forex Changes0000
Net Change in Cash(573K)226.28M259.27M(393.03M)
Free Cash Flow(32.27M)(46.21M)(74.82M)(107.11M)

Bicara Therapeutics Inc. Common Stock

NASDAQ:BCAX

Intrinsic Alpha fair value

Locked

Current Price

$9.38

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.